205 related articles for article (PubMed ID: 33779506)
1. Relative assessment of different statistical instruments and measures for the prediction of promising outcomes using docking, virtual screening and ADMET analysis against HIV-RT.
Shamshad H; Saeed M; Ul-Haq Z; Halim SA; Gul S; Mirza AZ
J Biomol Struct Dyn; 2022 Oct; 40(17):7680-7692. PubMed ID: 33779506
[TBL] [Abstract][Full Text] [Related]
2. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
[TBL] [Abstract][Full Text] [Related]
3. Docking-based virtual screening of TβR1 inhibitors: evaluation of pose prediction and scoring functions.
Wang S; Jiang JH; Li RY; Deng P
BMC Chem; 2020 Dec; 14(1):52. PubMed ID: 32818203
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the
Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
[TBL] [Abstract][Full Text] [Related]
5. Optimization of compound ranking for structure-based virtual ligand screening using an established FRED-Surflex consensus approach.
Du J; Bleylevens IW; Bitorina AV; Wichapong K; Nicolaes GA
Chem Biol Drug Des; 2014 Jan; 83(1):37-51. PubMed ID: 23941463
[TBL] [Abstract][Full Text] [Related]
6. PLHINT: A knowledge-driven computational approach based on the intermolecular H bond interactions at the protein-ligand interface from docking solutions.
Kumar SP
J Mol Graph Model; 2018 Jan; 79():194-212. PubMed ID: 29241118
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
[No Abstract] [Full Text] [Related]
8. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
[TBL] [Abstract][Full Text] [Related]
9. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
11. In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors.
Halim SA; Zaheer-Ul-Haq ; Khan A; Al-Rawahi A; Al-Harrasi A
Acta Pharm; 2021 Mar; 71(1):33-56. PubMed ID: 32697741
[TBL] [Abstract][Full Text] [Related]
12. Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond "Failure to rescue".
Chukwuemeka PO; Umar HI; Iwaloye O; Oretade OM; Olowosoke CB; Elabiyi MO; Igbe FO; Oretade OJ; Eigbe JO; Adeojo FJ
J Biomol Struct Dyn; 2022; 40(19):9158-9176. PubMed ID: 33988074
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.
Wang Z; Sun H; Yao X; Li D; Xu L; Li Y; Tian S; Hou T
Phys Chem Chem Phys; 2016 May; 18(18):12964-75. PubMed ID: 27108770
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
Jade DD; Pandey R; Kumar R; Gupta D
J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
[TBL] [Abstract][Full Text] [Related]
15. A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein-Protein Interfaces.
Singh N; Villoutreix BO
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430841
[TBL] [Abstract][Full Text] [Related]
16. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
17. Docking and scoring with ICM: the benchmarking results and strategies for improvement.
Neves MA; Totrov M; Abagyan R
J Comput Aided Mol Des; 2012 Jun; 26(6):675-86. PubMed ID: 22569591
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
19. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.
Wang N; Wang L; Xie XQ
J Chem Inf Model; 2017 Nov; 57(11):2686-2698. PubMed ID: 29016123
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening by 2-D fingerprints, shape and docking for discovering new chemotypes of activator protein-1 inhibitors.
Yin Z
J Biomol Struct Dyn; 2021 Apr; 39(7):2455-2462. PubMed ID: 32223539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
